THIOLOGICS - Trademark Details
Status: 709 - Registration cancelled because registrant did not file an acceptable declaration under Section 71
Serial Number
79115013
Registration Number
4452854
Word Mark
THIOLOGICS
Status
709 - Registration cancelled because registrant did not file an acceptable declaration under Section 71
Status Date
2021-02-26
Filing Date
2012-01-27
Registration Number
4452854
Registration Date
2013-12-24
Mark Drawing
4000 - Standard character mark
Typeset
Published for Opposition Date
2013-10-08
Attorney Name
Law Office Assigned Location Code
L50
Employee Name
TWOHIG, SHANNON MARIE
Statements
Goods and Services
Chemicals for use in bioconjugation, reversible bioconjugation, irreversible bioconjugation, reversible cysteine protection, surface modification, and prodrug production; biochemicals, namely, polypeptides, polypeptides for in vivo applications, polypeptides for in vitro applications, polynucleic acids, polynucleic acids for in vivo applications, and polynucleic acids for in vitro applications; biomolecules, namely, proteins, peptides, antibodies, antibody fragments, antibody mimetic proteins, and polynucleic acids; chemical products for diagnostic use, namely, conjugates of polypeptides with small molecule drugs, imaging agents, and radionuclides for medical applications; biochemical preparations, namely, polypeptides, polynucleic acids, and antibodies, all for use in medical research; biochemical preparations, namely, polypeptides, polynucleic acids, and antibodies, all for use in diagnosis and treatment of disease
Goods and Services
Pharmaceutical preparations, namely, polypeptide bioconjugates and polynucleic acid bioconjugates for use in diagnosis and treatment of autoimmune, cardiovascular, central nervous system, dental, dermatology, endocrine, gastrointestinal, genetic, hematology, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncology, ophthalmological, otolaryngology, psychiatric, respiratory, urogenital, urological and viral diseases and disorders in animals and humans; biological preparations, namely, polypeptide bioconjugates and polynucleic acid bioconjugates for use in diagnosis and treatment of autoimmune, cardiovascular, central nervous system, dental, dermatology, endocrine, gastrointestinal, genetic, hematology, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncology, ophthalmological, otolaryngology, psychiatric, respiratory, urogenital, urological and viral diseases and disorders in animals and humans; diagnostic preparations for medical purposes; diagnostic preparations for scientific or research use; diagnostic kits consisting primarily of antibody preparations, namely, antibody bioconjugates, namely, antibody-drug conjugates, antibody-radionuclide conjugates and antibody-imaging agent conjugates for use in diagnosis and treatment of autoimmune, cardiovascular, central nervous system, dental, dermatology, endocrine, gastrointestinal, genetic, hematology, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncology, ophthalmological, otolaryngology, psychiatric, respiratory, urogenital, urological and viral diseases and disorders in animals and humans; diagnostic kits consisting primarily of chemical products for medical diagnostic use, namely, polypeptide bioconjugates and polynucleic acid bioconjugates for use in diagnosis and treatment of autoimmune, cardiovascular, central nervous system, dental, dermatology, endocrine, gastrointestinal, genetic, hematology, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncology, ophthalmological, otolaryngology, psychiatric, respiratory, urogenital, urological and viral diseases and disorders in animals and humans; diagnostic kits consisting primarily of biochemical preparations, namely, polypeptide bioconjugates and polynucleic acid bioconjugates for use in diagnosis and treatment of autoimmune, cardiovascular, central nervous system, dental, dermatology, endocrine, gastrointestinal, genetic, hematology, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncology, ophthalmological, otolaryngology, psychiatric, respiratory, urogenital, urological and viral diseases and disorders in animals and humans
Goods and Services
Scientific and technological services, namely, design and assembly of polypeptide bioconjugates and polynucleic acid bioconjugates, and design and optimization of proprietary bioconjugation technologies; biological research; chemical research and analysis; scientific advisory services relating to research and development in the field of diagnostic preparations and diagnostic products; providing scientific information and advisory services in the fields of scientific research and design, and biological and chemical research
Pseudo Mark
THIO LOGICS
Classification Information
International Class
001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins, unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins, unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes
001, 005, 006, 010, 026, 046
Class Status Code
F - Section 71 - Cancelled
Class Status Date
2021-02-26
Primary Code
001
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
F - Section 71 - Cancelled
Class Status Date
2021-02-26
Primary Code
005
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
F - Section 71 - Cancelled
Class Status Date
2021-02-26
Primary Code
042
Correspondences
Name
Joel D. Voelzke
Address
Please log in with your Justia account to see this address.
International Registrations
International Registration Number
1121712
International Registration Date
2012-01-27
International Publication Date
2012-08-09
International Renewal Date
2022-01-27
Auto Protection Date
2014-02-02
International Status
001 - Request for extension of protection established
International Status Date
2012-08-02
Priority Claimed In
True
Priority Claimed Date
2011-07-27
First Refusal In
True
Trademark Events
| Event Date | Event Description |
| 2012-08-02 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| 2012-08-03 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| 2012-08-03 | ASSIGNED TO EXAMINER |
| 2012-08-06 | NON-FINAL ACTION WRITTEN |
| 2012-08-07 | APPLICATION FILING RECEIPT MAILED |
| 2012-08-07 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| 2012-08-07 | REFUSAL PROCESSED BY MPU |
| 2012-08-07 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| 2012-08-30 | REFUSAL PROCESSED BY IB |
| 2013-02-06 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 2013-02-07 | ASSIGNED TO LIE |
| 2013-02-14 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2013-02-14 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2013-03-07 | FINAL REFUSAL WRITTEN |
| 2013-03-07 | FINAL REFUSAL E-MAILED |
| 2013-03-07 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| 2013-08-20 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| 2013-08-20 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2013-08-20 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2013-08-22 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 2013-08-30 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| 2013-09-18 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 2013-09-18 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| 2013-09-18 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| 2013-10-07 | NOTIFICATION PROCESSED BY IB |
| 2013-10-08 | PUBLISHED FOR OPPOSITION |
| 2013-10-08 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 2013-12-24 | REGISTERED-PRINCIPAL REGISTER |
| 2014-03-24 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| 2014-05-19 | FINAL DISPOSITION PROCESSED |
| 2014-05-19 | FINAL DISPOSITION NOTICE SENT TO IB |
| 2014-06-06 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| 2018-12-24 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED |
| 2021-02-26 | CANCELLED SECTION 71 |
| 2021-10-02 | NEW REPRESENTATIVE AT IB RECEIVED |
| 2021-10-26 | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED |
| 2021-12-23 | INVALIDATION PROCESSED |
| 2021-12-23 | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB |
| 2022-01-29 | TOTAL INVALIDATION PROCESSED BY THE IB |
